You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 144 No. 4, April 2008 TABLE OF CONTENTS
  Archives
  •  Online Features
  Study
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (1)
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in this journal
 Topic Collections
 •Dermatologic Disorders
 •Neoplasms
 •Diagnosis
 •Prognosis/ Outcomes
 •Dermatologic Disorders, Other
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati
What's this?

Lymphatic Invasion Identified by Monoclonal Antibody D2-40, Younger Age, and Ulceration

Predictors of Sentinel Lymph Node Involvement in Primary Cutaneous Melanoma

Firouzeh Niakosari, MD; Harriette J. Kahn, MD; David McCready, MD; Danny Ghazarian, MD; Lorne E. Rotstein, MD; Alexander Marks, MD; Alexander Kiss, PhD; Lynn From, MD

Arch Dermatol. 2008;144(4):462-467.

Objectives  To assess whether lymphatic invasion identified by immunostaining with monoclonal antibody (Mab) D2-40 in primary cutaneous melanomas correlates with other clinicopathologic factors and to assess whether lymphatic invasion is a potential predictor of sentinel lymph node (SLN) status.

Design  Retrospective case-series study.

Setting  Academic referral center.

Patients  Ninety-six consecutive patients with primary cutaneous melanomas 1 mm thick or greater with adequate pathologic material available for immunohistochemical studies and SLN biopsy.

Main Outcome Measures  Association between lymphatic invasion identified by immunostaining with Mab D2-40 in primary cutaneous melanoma and correlation with the clinicopathologic features and the association of all of the factors with SLN status.

Results  Lymphatic invasion identified by immunostaining with Mab D2-40 was significantly associated with deeper Clark level of invasion (P < .001), and greater Breslow tumor thickness (P = .01) SLN positivity was identified in 23 of 96 cases (24%). At univariate analysis, younger age (P = .03), ulceration (P < .006), lymphatic invasion (P < .02), deeper Clark level of invasion (P < .008), Breslow tumor thickness (P = .008), and tumor site on the trunk (P = .02) were significantly associated with SLN metastases. At multivariate analysis, only younger age (P = .04), ulceration (P = .03), and lymphatic invasion detected by immunostaining with Mab D2-40 (P = .01) were significantly associated with SLN positivity. The probability of SLN positivity was 13% when all 3 independent prognostic factors yielded negative findings and increased to 61% when all 3 variables yielded positive findings.

Conclusions  Breslow tumor thickness, Clark level of invasion, and tumor site on the trunk predicted SLN status at univariate analysis. Multivariate regression analysis showed that lymphatic invasion identified by immunostaining with Mab D2-40, younger age, and ulceration were the only independent prognostic factors. The most significant predictor of SLN metastasis was the positivity of all 3 independent prognostic factors (61%). Findings of this study suggest that assessment of lymphatic invasion by immunostaining with Mab D2-40 with other clinicopathologic factors can be used to identify patients who could be spared the need for SLN biopsy.


Author Affiliations: Departments of Pathology (Drs Niakosari, Kahn, and Ghazarian), General Surgery (Drs McCready and Rotstein), and Dermatology (Dr From), Sunnybrook Health Sciences Centre, University Health Network; Banting and Best Department of Medical Research (Dr Marks); and Institute for Clinical Evaluative Sciences (Dr Kiss), University of Toronto, Toronto, Ontario, Canada.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati     What's this?

RELATED ARTICLE

Lymphangiogenesis: Host and Tumor Factors in Nodal Metastasis
Vernon K. Sondak and Jane L. Messina
Arch Dermatol. 2008;144(4):536-537.
EXTRACT | FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Increased Vascular Endothelial Growth Factor-C Expression Is Insufficient to Induce Lymphatic Metastasis in Human Soft-Tissue Sarcomas
Lahat et al.
Clin. Cancer Res. 2009;15:2637-2646.
ABSTRACT | FULL TEXT  

Lymphangiogenesis Induced by Surgery: A Risk for Melanoma Metastasis--Reply
Messina and Sondak
Arch Dermatol 2009;145:90-90.
FULL TEXT  

Lymphangiogenesis: Host and Tumor Factors in Nodal Metastasis
Sondak and Messina
Arch Dermatol 2008;144:536-537.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2008 American Medical Association. All Rights Reserved.